5.Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.

Masuda H, Kobayashi T, Hachiya A, Nakashima Y, Shimizu H, Nozawa T, Ogihara Y, Ito S, Takatsuki S, Katsumata N, Suzuki Y, Takenaka S, Hirono K, Kobayashi T, Suzuki H, Suganuma E, Takahashi K, Saji T

Research output: Contribution to journalArticlepeer-review

Original languageJapanese
Pages (from-to)115-120.e3
Journal日本小児血液・がん学会雑誌
Volume-
DOIs
StatePublished - 2017
Externally publishedYes

Cite this